- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
CB Therapeutics Funding
CB Therapeutics is active in the following markets / industries: biotechnology, pharmaceuticals, synthetic biology and marijuana. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on January 10, 2019.
Funding Rounds
S
$4000000PRE
$2200000